Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析

◆英語タイトル:Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH58486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amarin Corp Plc (AMRN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amarin Corp Plc (Amarin) is a pharmaceutical company which develops and commercializes medicines for cardiovascular diseases. The company’s lead product, Vascepa (icosapent ethyl), is a single-molecule prescription capsule used as an adjunct to diet for the reduction of triglyceride levels in adult patients with severe hypertriglyceridemia and high triglyceride levels or mixed dyslipidemia andcardiovascular risk. The company is also evaluating Vascepa as an add-on therapy to reduce major cardiovascular events in an at-risk patient population on statin therapy. Amarin markets the product in the US through wholesalers and specialty pharmacy providers. The company has operations in Ireland, the US, Germany, Switzerland, the Uk, Italy, France and Israel. Amarin is headquartered at Dublin, Ireland.

Amarin Corp Plc Key Recent Developments

Feb 25,2021: Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17,2021: Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
Jan 07,2021: Amarin provides preliminary 2020 results and 2021 outlook
Nov 30,2020: Amarin files patent infringement lawsuit against Hikma
Nov 05,2020: Amarin reports third quarter 2020 financial results and provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amarin Corp Plc – Key Facts
Amarin Corp Plc – Key Employees
Amarin Corp Plc – Key Employee Biographies
Amarin Corp Plc – Major Products and Services
Amarin Corp Plc – History
Amarin Corp Plc – Company Statement
Amarin Corp Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amarin Corp Plc – Business Description
Product Category: Licensing Revenue
Overview
Performance
Product Category: Vascepa
Overview
Performance
R&D Overview
Amarin Corp Plc – SWOT Analysis
SWOT Analysis – Overview
Amarin Corp Plc – Strengths
Amarin Corp Plc – Weaknesses
Amarin Corp Plc – Opportunities
Amarin Corp Plc – Threats
Amarin Corp Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amarin Corp Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17, 2021: Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
Jan 07, 2021: Amarin provides preliminary 2020 results and 2021 outlook
Nov 30, 2020: Amarin files patent infringement lawsuit against Hikma
Nov 05, 2020: Amarin reports third quarter 2020 financial results and provides business update
Aug 04, 2020: Amarin reports second quarter 2020 financial results and provides update on operations
Apr 30, 2020: Amarin reports first quarter 2020 financial results and provides update on operations
Apr 28, 2020: Amarin to Report First Quarter 2020 Results and Host Conference Call on April 30, 2020
Feb 25, 2020: Amarin reports record fourth quarter and full year 2019 financial results and provides update on operations
Jan 13, 2020: Amarin launches true to your heart, a campaign to educate people on persistent cardiovascular risk
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amarin Corp Plc, Key Facts
Amarin Corp Plc, Key Employees
Amarin Corp Plc, Key Employee Biographies
Amarin Corp Plc, Major Products and Services
Amarin Corp Plc, History
Amarin Corp Plc, Subsidiaries
Amarin Corp Plc, Key Competitors
Amarin Corp Plc, Ratios based on current share price
Amarin Corp Plc, Annual Ratios
Amarin Corp Plc, Annual Ratios (Cont...1)
Amarin Corp Plc, Interim Ratios
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amarin Corp Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ASIT Biotech SA (ASIT):製薬・医療:M&Aディール及び事業提携情報
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • TC Pipelines LP (TCP):石油・ガス:M&Aディール及び事業提携情報
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • The Finish Line Inc:企業の戦略・SWOT・財務分析
    The Finish Line Inc - Strategy, SWOT and Corporate Finance Report Summary The Finish Line Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Valiant Holding AG:企業の戦略・SWOT・財務分析
    Valiant Holding AG - Strategy, SWOT and Corporate Finance Report Summary Valiant Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • Yokogawa Electric Corporation:企業の戦略・SWOT・財務分析
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Chevron Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Canada Ltd (CCL), a subsidiary of Chevron Corporation is an oil and gas company that refines and produces oil and natural gas products. The company explores, develops, produces and markets crude oil, natural gas and natural gas liquids. Its activities include drilling, facilities, ic …
  • Saudi Electricity Co:企業の発電所・SWOT分析2018
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Proteus Digital Health Inc:企業の戦略的SWOT分析
    Proteus Digital Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Esteve Pharmaceuticals SA:企業の戦略的SWOT分析
    Esteve Pharmaceuticals SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Windtree Therapeutics Inc (WINT)-医療機器分野:企業M&A・提携分析
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Dana Incorporated:戦略・SWOT・企業財務分析
    Dana Incorporated - Strategy, SWOT and Corporate Finance Report Summary Dana Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zirax Ltd:企業の戦略的SWOT分析
    Zirax Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Wentworth Resources Ltd (WRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wentworth Resources Ltd (Wentworth) is an independent upstream oil and gas company. It conducts the exploration and development of oil and natural gas reserves. The company has producing gas assets in Tanzania, oil and gas exploration activities in both Mozambique and Tanzania. The company o …
  • Checkpoint Surgical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Checkpoint Surgical LLC (Checkpoint Surgical) is a medical device company that offers neuro-protective surgery equipment. The company offers neuro-protective devices including checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators p …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Stericycle, Inc. (SRCL):企業の財務・戦略的SWOT分析
    Stericycle, Inc. (SRCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, PMX, SAMI, toraymyxin and reagents. Its EAA is an endotoxin activity assay, which …
  • DCC Plc (DCC):石油・ガス:M&Aディール及び事業提携情報
    Summary DCC Plc (DCC) is a diversified company that offers international sales, marketing, distribution and business support services. The company operates through its business divisions such as LPG, retail, and oil, healthcare and technology. Its LPG business markets liquefied petroleum gas and nat …
  • Arkansas Electric Cooperative Corporation:発電所・企業SWOT分析
    Arkansas Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆